Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1474-760X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts ; volume:21 ; number:1 ; day:26 ; month:3 ; year:2020 ; pages:1-13 ; date:12.2020
Genome biology ; 21, Heft 1 (26.3.2020), 1-13, 12.2020
- Urheber
-
Mullin, Benjamin H.
Tickner, Jennifer
Zhu, Kun
Kenny, Jacob
Mullin, Shelby
Brown, Suzanne J.
Dudbridge, Frank
Pavlos, Nathan J.
Mocarski, Edward S.
Walsh, John P.
Xu, Jiake
Wilson, Scott G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13059-020-01997-2
- URN
-
urn:nbn:de:101:1-2020061623460518531444
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mullin, Benjamin H.
- Tickner, Jennifer
- Zhu, Kun
- Kenny, Jacob
- Mullin, Shelby
- Brown, Suzanne J.
- Dudbridge, Frank
- Pavlos, Nathan J.
- Mocarski, Edward S.
- Walsh, John P.
- Xu, Jiake
- Wilson, Scott G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
Comparative transcriptomic analysis identifies distinct molecular signatures and regulatory networks of chondroclasts and osteoclasts
Interpreting regulatory variants with predictive models
Giant osteoclasts in patients under bisphosphonates
Cell-cell fusion: human multinucleated osteoclasts
Angelicin improves osteoporosis in ovariectomized rats by reducing ROS production in osteoclasts through regulation of the KAT6A/Nrf2 signalling pathway
Negative feedback buffers effects of regulatory variants
Down-regulation of FTX promotes the differentiation of osteoclasts in osteoporosis through the Notch1 signaling pathway by targeting miR-137
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
Comparative transcriptomic analysis identifies distinct molecular signatures and regulatory networks of chondroclasts and osteoclasts
Interpreting regulatory variants with predictive models
Giant osteoclasts in patients under bisphosphonates
Cell-cell fusion: human multinucleated osteoclasts
Angelicin improves osteoporosis in ovariectomized rats by reducing ROS production in osteoclasts through regulation of the KAT6A/Nrf2 signalling pathway
Negative feedback buffers effects of regulatory variants
Down-regulation of FTX promotes the differentiation of osteoclasts in osteoporosis through the Notch1 signaling pathway by targeting miR-137
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
Comparative transcriptomic analysis identifies distinct molecular signatures and regulatory networks of chondroclasts and osteoclasts
Interpreting regulatory variants with predictive models
Giant osteoclasts in patients under bisphosphonates
Cell-cell fusion: human multinucleated osteoclasts
Angelicin improves osteoporosis in ovariectomized rats by reducing ROS production in osteoclasts through regulation of the KAT6A/Nrf2 signalling pathway
Negative feedback buffers effects of regulatory variants